Cargando…

Multi-Parametric Evaluation of Chronic Kidney Disease by MRI: A Preliminary Cross-Sectional Study

BACKGROUND: The current clinical classification of chronic kidney disease (CKD) is not perfect and may be overestimating both the prevalence and the risk for progressive disease. Novel markers are being sought to identify those at risk of progression. This preliminary study evaluates the feasibility...

Descripción completa

Detalles Bibliográficos
Autores principales: Prasad, Pottumarthi V., Thacker, Jon, Li, Lu-Ping, Haque, Muhammad, Li, Wei, Koenigs, Heather, Zhou, Ying, Sprague, Stuart M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4591972/
https://www.ncbi.nlm.nih.gov/pubmed/26430736
http://dx.doi.org/10.1371/journal.pone.0139661
_version_ 1782393137054875648
author Prasad, Pottumarthi V.
Thacker, Jon
Li, Lu-Ping
Haque, Muhammad
Li, Wei
Koenigs, Heather
Zhou, Ying
Sprague, Stuart M.
author_facet Prasad, Pottumarthi V.
Thacker, Jon
Li, Lu-Ping
Haque, Muhammad
Li, Wei
Koenigs, Heather
Zhou, Ying
Sprague, Stuart M.
author_sort Prasad, Pottumarthi V.
collection PubMed
description BACKGROUND: The current clinical classification of chronic kidney disease (CKD) is not perfect and may be overestimating both the prevalence and the risk for progressive disease. Novel markers are being sought to identify those at risk of progression. This preliminary study evaluates the feasibility of magnetic resonance imaging based markers to identify early changes in CKD. METHODS: Fifty-nine subjects (22 healthy, 7 anemics with no renal disease, 30 subjects with CKD) participated. Data using 3D volume imaging, blood oxygenation level dependent (BOLD) and Diffusion MRI was acquired. BOLD MRI acquisition was repeated after 20 mg of iv furosemide. RESULTS: Compared to healthy subjects, those with CKD have lower renal parenchymal volumes (329.6±66.4 vs. 257.1±87.0 ml, p<0.005), higher cortical R2* values (19.7±3.2 vs. 23.2±6.3 s(−1), p = 0.013) (suggesting higher levels of hypoxia) and lower response to furosemide on medullary R2* (6.9±3.3 vs. 3.1±7.5 s(−1), p = 0.02). All three parameters showed significant correlation with estimated glomerular filtration rate (eGFR). When the groups were matched for age and sex, cortical R2* and kidney volume still showed significant differences between CKD and healthy controls. The most interesting observation is that a small number of subjects (8 of 29) contributed to the increase in mean value observed in CKD. The difference in cortical R2* between these subjects compared to the rest were highly significant and had a large effect size (Cohen’s d = 3.5). While highly suggestive, future studies may be necessary to verify if such higher levels of hypoxia are indicative of progressive disease. Diffusion MRI showed no differences between CKD and healthy controls. CONCLUSIONS: These data demonstrate that BOLD MRI can be used to identify enhanced hypoxia associated with CKD and the preliminary observations are consistent with the chronic hypoxia model for disease progression in CKD. Longitudinal studies are warranted to further verify these findings and assess their predictive value.
format Online
Article
Text
id pubmed-4591972
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-45919722015-10-09 Multi-Parametric Evaluation of Chronic Kidney Disease by MRI: A Preliminary Cross-Sectional Study Prasad, Pottumarthi V. Thacker, Jon Li, Lu-Ping Haque, Muhammad Li, Wei Koenigs, Heather Zhou, Ying Sprague, Stuart M. PLoS One Research Article BACKGROUND: The current clinical classification of chronic kidney disease (CKD) is not perfect and may be overestimating both the prevalence and the risk for progressive disease. Novel markers are being sought to identify those at risk of progression. This preliminary study evaluates the feasibility of magnetic resonance imaging based markers to identify early changes in CKD. METHODS: Fifty-nine subjects (22 healthy, 7 anemics with no renal disease, 30 subjects with CKD) participated. Data using 3D volume imaging, blood oxygenation level dependent (BOLD) and Diffusion MRI was acquired. BOLD MRI acquisition was repeated after 20 mg of iv furosemide. RESULTS: Compared to healthy subjects, those with CKD have lower renal parenchymal volumes (329.6±66.4 vs. 257.1±87.0 ml, p<0.005), higher cortical R2* values (19.7±3.2 vs. 23.2±6.3 s(−1), p = 0.013) (suggesting higher levels of hypoxia) and lower response to furosemide on medullary R2* (6.9±3.3 vs. 3.1±7.5 s(−1), p = 0.02). All three parameters showed significant correlation with estimated glomerular filtration rate (eGFR). When the groups were matched for age and sex, cortical R2* and kidney volume still showed significant differences between CKD and healthy controls. The most interesting observation is that a small number of subjects (8 of 29) contributed to the increase in mean value observed in CKD. The difference in cortical R2* between these subjects compared to the rest were highly significant and had a large effect size (Cohen’s d = 3.5). While highly suggestive, future studies may be necessary to verify if such higher levels of hypoxia are indicative of progressive disease. Diffusion MRI showed no differences between CKD and healthy controls. CONCLUSIONS: These data demonstrate that BOLD MRI can be used to identify enhanced hypoxia associated with CKD and the preliminary observations are consistent with the chronic hypoxia model for disease progression in CKD. Longitudinal studies are warranted to further verify these findings and assess their predictive value. Public Library of Science 2015-10-02 /pmc/articles/PMC4591972/ /pubmed/26430736 http://dx.doi.org/10.1371/journal.pone.0139661 Text en © 2015 Prasad et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Prasad, Pottumarthi V.
Thacker, Jon
Li, Lu-Ping
Haque, Muhammad
Li, Wei
Koenigs, Heather
Zhou, Ying
Sprague, Stuart M.
Multi-Parametric Evaluation of Chronic Kidney Disease by MRI: A Preliminary Cross-Sectional Study
title Multi-Parametric Evaluation of Chronic Kidney Disease by MRI: A Preliminary Cross-Sectional Study
title_full Multi-Parametric Evaluation of Chronic Kidney Disease by MRI: A Preliminary Cross-Sectional Study
title_fullStr Multi-Parametric Evaluation of Chronic Kidney Disease by MRI: A Preliminary Cross-Sectional Study
title_full_unstemmed Multi-Parametric Evaluation of Chronic Kidney Disease by MRI: A Preliminary Cross-Sectional Study
title_short Multi-Parametric Evaluation of Chronic Kidney Disease by MRI: A Preliminary Cross-Sectional Study
title_sort multi-parametric evaluation of chronic kidney disease by mri: a preliminary cross-sectional study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4591972/
https://www.ncbi.nlm.nih.gov/pubmed/26430736
http://dx.doi.org/10.1371/journal.pone.0139661
work_keys_str_mv AT prasadpottumarthiv multiparametricevaluationofchronickidneydiseasebymriapreliminarycrosssectionalstudy
AT thackerjon multiparametricevaluationofchronickidneydiseasebymriapreliminarycrosssectionalstudy
AT liluping multiparametricevaluationofchronickidneydiseasebymriapreliminarycrosssectionalstudy
AT haquemuhammad multiparametricevaluationofchronickidneydiseasebymriapreliminarycrosssectionalstudy
AT liwei multiparametricevaluationofchronickidneydiseasebymriapreliminarycrosssectionalstudy
AT koenigsheather multiparametricevaluationofchronickidneydiseasebymriapreliminarycrosssectionalstudy
AT zhouying multiparametricevaluationofchronickidneydiseasebymriapreliminarycrosssectionalstudy
AT spraguestuartm multiparametricevaluationofchronickidneydiseasebymriapreliminarycrosssectionalstudy